PhysioGenix aims to be the global leader in preclinical research services for diabetes, cardiovascular disease, and renal disease studies. With in-house capabilities and expert consultants, the company offers comprehensive solutions for research needs. The highly skilled team provides personalized services to a diverse range of clients, from top pharmaceutical and biotechnology companies to early-stage research companies. PhysioGenix is committed to developing customized research programs and carrying out projects with precision and accountability. The company specializes in preclinical pharmacology services for metabolic disorders, including obesity, diabetes, and cardiovascular diseases.
Show More